[HTML][HTML] Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments
A Gupta, A Konnova, M Smet, M Berkell… - The Journal of …, 2023 - Am Soc Clin Investig
Background The role of host immunity in emergence of evasive SARS-CoV-2 Spike mutations
under therapeutic monoclonal antibody (mAb) pressure remains to be explored. Methods …
under therapeutic monoclonal antibody (mAb) pressure remains to be explored. Methods …
[HTML][HTML] Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort
…, S Gioiosa, JM Naranjo, M Ortali, A Konnova… - …, 2023 - thelancet.com
Background Lack of specific definitions of clinical characteristics, disease severity, and risk
and preventive factors of post-COVID-19 syndrome (PCS) severely impacts research and …
and preventive factors of post-COVID-19 syndrome (PCS) severely impacts research and …
Activation of the integrated stress response confers vulnerability to mitoribosome-targeting antibiotics in melanoma
…, V Katopodi, S Cinque, A Konnova… - Journal of Experimental …, 2021 - rupress.org
The ability to adapt to environmental stress, including therapeutic insult, contributes to tumor
evolution and drug resistance. In suboptimal conditions, the integrated stress response (ISR…
evolution and drug resistance. In suboptimal conditions, the integrated stress response (ISR…
[HTML][HTML] Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
FHR De Winter, A Hotterbeekx, MT Huizing, A Konnova… - Cancers, 2021 - mdpi.com
Simple Summary SARS-CoV-2 infection has been associated with broad dysregulation of
the circulating immune system and inflammation that could persist for a long period. Chronic …
the circulating immune system and inflammation that could persist for a long period. Chronic …
Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort
…, E Righi, J Hasenauer, L Marconi, A Konnova… - Clinical Microbiology …, 2023 - Elsevier
Objectives The study aim was to assess predictors of negative antibody response (AbR) in
solid organ transplant (SOT) recipients after the first booster of SARS-CoV-2 vaccination. …
solid organ transplant (SOT) recipients after the first booster of SARS-CoV-2 vaccination. …
[HTML][HTML] Clinical efficacy of different monoclonal antibody regimens among non-hospitalised patients with mild to moderate COVID-19 at high risk for disease …
This study aimed to compare the clinical progression of COVID-19 in high-risk outpatients
treated with the monoclonal antibodies (mAb) bamlanivimab, bamlanivimab-etesevimab and …
treated with the monoclonal antibodies (mAb) bamlanivimab, bamlanivimab-etesevimab and …
[HTML][HTML] Clinical impact of monoclonal antibodies in the treatment of high-risk patients with SARS-CoV-2 breakthrough infections: The ORCHESTRA Prospective …
…, M Mirandola, M Berkell, M Smet, A Konnova… - Biomedicines, 2022 - mdpi.com
The clinical impact of anti-spike monoclonal antibodies (mAb) in Coronavirus Disease 2019
(COVID-19) breakthrough infections is unclear. We present the results of an observational …
(COVID-19) breakthrough infections is unclear. We present the results of an observational …
How storytelling can combat vaccine hesitancy: a transdisciplinary approach
J Laura, K Tarunjose, K Angelina… - Transdisciplinary …, 2018 - ingentaconnect.com
The recent decline in vaccination rates across Europe has led to outbreaks of vaccine
preventable diseases such as measles. Although there have always been persons opposed to …
preventable diseases such as measles. Although there have always been persons opposed to …
[HTML][HTML] Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors
A Konnova, FHR De Winter, A Gupta… - Frontiers in …, 2022 - frontiersin.org
Background Patients with cancer, especially hematological cancer, are at increased risk for
breakthrough COVID-19 infection. So far, a predictive biomarker that can assess …
breakthrough COVID-19 infection. So far, a predictive biomarker that can assess …
Predictive model for BNT162b2 vaccine response in cancer patients based on cytokines and growth factors
A Konnova, FHR De Winter, A Gupta, L Verbruggen… - medRxiv, 2022 - medrxiv.org
Background Patients with cancer, especially haematological cancer, are at increased risk for
breakthrough COVID-19 infection. However, so far, a predictive biomarker that can assess …
breakthrough COVID-19 infection. However, so far, a predictive biomarker that can assess …